These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18647893)

  • 1. Double-contrast MRI in patients with cirrhosis.
    Guiu B; Loffroy R; Cercueil JP
    AJR Am J Roentgenol; 2008 Aug; 191(2):W78. PubMed ID: 18647893
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis.
    Hanna RF; Kased N; Kwan SW; Gamst AC; Santosa AC; Hassanein T; Sirlin CB
    AJR Am J Roentgenol; 2008 Jan; 190(1):47-57. PubMed ID: 18094293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI findings of hepatocellular carcinoma.
    Wiwanitkit V
    Magn Reson Imaging; 2011 Feb; 29(2):303. PubMed ID: 21129874
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI.
    Kumada T; Toyoda H; Tada T; Sone Y; Fujimori M; Ogawa S; Ishikawa T
    AJR Am J Roentgenol; 2011 Jul; 197(1):58-63. PubMed ID: 21701011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI findings of rapidly progressive hepatocellular carcinoma.
    Kierans AS; Leonardou P; Hayashi P; Brubaker LM; Elazzazi M; Shaikh F; Semelka RC
    Magn Reson Imaging; 2010 Jul; 28(6):790-6. PubMed ID: 20427139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective audit to determine the diagnostic accuracy of Primovist-enhanced MRI in the detection of hepatocellular carcinoma in cirrhosis with explant histopathology correlation.
    Baird AJ; Amos GJ; Saad NF; Benson MD
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):314-20. PubMed ID: 23721140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration.
    Golfieri R; Grazioli L; Orlando E; Dormi A; Lucidi V; Corcioni B; Dettori E; Romanini L; Renzulli M
    J Magn Reson Imaging; 2012 Sep; 36(3):648-57. PubMed ID: 22592930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
    Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
    J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal carcinoma: double-contrast MR imaging for preoperative staging.
    Wallengren NO; Holtås S; Andrén-Sandberg A; Jonsson E; Kristoffersson DT; McGill S
    Radiology; 2000 Apr; 215(1):108-14. PubMed ID: 10751475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD; Kizziah MK; Rissing MS
    J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
    Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamic MRI].
    Araki T; Ichikawa T; Nakajima H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
    [No Abstract]   [Full Text] [Related]  

  • 16. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
    Sangiovanni A; Manini MA; Iavarone M; Romeo R; Forzenigo LV; Fraquelli M; Massironi S; Della Corte C; Ronchi G; Rumi MG; Biondetti P; Colombo M
    Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease.
    Motosugi U; Ichikawa T; Sano K; Sou H; Onohara K; Muhi A; Kitamura T; Amemiya F; Enomoto N; Matsuda M; Asakawa M; Fujii H; Araki T
    Invest Radiol; 2011 Feb; 46(2):141-5. PubMed ID: 21139506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional contrast-enhanced hepatic MR imaging: comparison between a centric technique and a linear approach with partial Fourier along both slice and phase directions.
    Kim KA; Herigault G; Kim MJ; Chung YE; Hong HS; Choi SY
    J Magn Reson Imaging; 2011 Jan; 33(1):160-6. PubMed ID: 21182134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.
    Frericks BB; Loddenkemper C; Huppertz A; Valdeig S; Stroux A; Seja M; Wolf KJ; Albrecht T
    AJR Am J Roentgenol; 2009 Oct; 193(4):1053-60. PubMed ID: 19770329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.